• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Adma Biologics (NQ: ADMA )

    13.79 +0.43 (+3.18%)
    Streaming Delayed Price Updated: 1:24 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,289,756
    Open 13.50
    Bid (Size) 13.78 (4)
    Ask (Size) 13.79 (5)
    Prev. Close 13.36
    Today's Range 13.47 - 13.93
    52wk Range 3.060 - 13.84
    Shares Outstanding 196,357,149
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    Biotech Arvinas Stock Earns 82 RS Rating
    The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82. 
    Via Investor's Business Daily

    Performance

    YTD
    +202.97%
    +202.97%
    1 Month
    +25.32%
    +25.32%
    3 Month
    +122.34%
    +122.34%
    6 Month
    +160.59%
    +160.59%
    1 Year
    +269.57%
    +269.57%

    More News

    Read More
    Denali Therapeutics Stock Gets Technical Rating Upgrade
    Via Investor's Business Daily
    3 Millionaire-Making Stock Picks With Astounding Growth Potential
    Via InvestorPlace
    How Is The Market Feeling About ADMA Biologics?
    Via Benzinga
    Bull Run Alert: 3 Stocks Set to Soar in the Coming Months
    Via InvestorPlace
    Expert Ratings For ADMA Biologics
    Via Benzinga
    Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
    Via Benzinga
    ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results
    Via Benzinga
    UroGen Pharma Stock Earns 91 RS Rating
    Via Investor's Business Daily
    Arcellx Stock Earns Relative Strength Rating Upgrade
    Via Investor's Business Daily
    Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
    Via Investor's Business Daily
    Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
    Via Investor's Business Daily
    Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
    Via Investor's Business Daily
    Krystal Biotech Stock Sees RS Rating Jump To 91
    Via Investor's Business Daily
    A Closer Look at 6 Analyst Recommendations For ADMA Biologics
    Via Benzinga
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    Chart Of The Day: ADMA Biologics - Hitting New Highs
    Via Talk Markets
    ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
    From ADMA Biologics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.